|
SET expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.325800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.988200E-01 |
| Normal-vs-Stage2 |
2.564800E-01 |
| Normal-vs-Stage3 |
1.287030E-01 |
| Normal-vs-Stage4 |
6.482100E-02 |
| Stage1-vs-Stage2 |
7.586200E-01 |
| Stage1-vs-Stage3 |
4.133200E-01 |
| Stage1-vs-Stage4 |
1.095430E-01 |
| Stage2-vs-Stage3 |
6.949800E-01 |
| Stage2-vs-Stage4 |
1.716590E-01 |
| Stage3-vs-Stage4 |
3.078400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.124040E-01 |
| Normal-vs-AfricanAmerican |
3.681700E-02 |
| Normal-vs-Asian |
8.296200E-01 |
| Caucasian-vs-AfricanAmerican |
3.945600E-01 |
| Caucasian-vs-Asian |
4.658400E-01 |
| AfricanAmerican-vs-Asian |
2.457200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.049150E-01 |
| Normal-vs-Female |
4.888000E-02 |
| Male-vs-Female |
3.668800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.315400E-01 |
| Normal-vs-Extreme_Weight |
3.436200E-01 |
| Normal-vs-Obese |
1.099840E-02 |
| Normal-vs-Extreme_Obese |
5.171800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.825800E-01 |
| Normal_Weight-vs-Obese |
1.207210E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.571400E-01 |
| Extreme_Weight-vs-Obese |
6.793900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.463200E-01 |
| Obese-vs-Extreme_Obese |
9.887700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.589560E-01 |
| Normal-vs-Age(41-60Yrs) |
3.838600E-03 |
| Normal-vs-Age(61-80Yrs) |
6.350800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.827400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.229400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.316200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.206600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.544300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.653200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.268200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.168390E-02 |
| Normal-VS-Type2 PRCC |
7.304400E-01 |
| Normal-VS-KIRP CIMP |
6.132400E-02 |
| Normal-VS-Unclassified PRCC |
3.912000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.044300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.801980E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.029800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.130100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.285800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.993800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.122600E-01 |
| Normal-vs-N1 |
7.702800E-03 |
| Normal-vs-N2 |
7.408800E-01 |
| N0-vs-N1 |
3.164900E-03 |
| N0-vs-N2 |
6.061400E-01 |
| N1-vs-N2 |
3.003000E-01 |
|
|
